Evidence map›Paper›PMID 31337854›Full record

ArticleJournal of human genetics2019

Comprehensive genetic analysis of 57 families with clinically suspected Cornelia de Lange syndrome.

Hiromi Aoi, Takeshi Mizuguchi, José Ricard Ceroni, Veronica Eun Hue Kim, Isabel Furquim, Rachel S Honjo, Takuma Iwaki, Toshifumi Suzuki, Futoshi Sekiguchi, Yuri Uchiyama and 12 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 59 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Frontiers in cell and developmental biology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 2 countries.

Hiromi AoiDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Takeshi MizuguchiDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
José Ricard CeroniClinical Genetics Unit, Instituto da Crianca, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
Veronica Eun Hue KimClinical Genetics Unit, Instituto da Crianca, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
Isabel FurquimClinical Genetics Unit, Instituto da Crianca, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
Rachel S HonjoClinical Genetics Unit, Instituto da Crianca, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
Takuma IwakiDepartment of Pediatrics, University Hospital, Faculty of Medicine, Kagawa University, Kagawa, Japan.ORCID http://orcid.org/0000-0002-3518-6269
Toshifumi SuzukiDepartment of Obstetrics and Gynecology, Juntendo University, Tokyo, Japan.
Futoshi SekiguchiDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Yuri UchiyamaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.ORCID http://orcid.org/0000-0002-4540-5277
Yoshiteru AzumaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Kohei HamanakaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Eriko KoshimizuDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Satoko MiyatakeDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Satomi MitsuhashiDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Atsushi TakataDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Noriko MiyakeDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Satoru TakedaDepartment of Obstetrics and Gynecology, Juntendo University, Tokyo, Japan.
Atsuo ItakuraDepartment of Obstetrics and Gynecology, Juntendo University, Tokyo, Japan.
Débora R BertolaClinical Genetics Unit, Instituto da Crianca, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
Chong Ae KimClinical Genetics Unit, Instituto da Crianca, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
Naomichi MatsumotoDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan. naomat@yokohama-cu.ac.jp.ORCID http://orcid.org/0000-0001-9846-6500
Yokohama City University · JPHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRJuntendo University · JPKagawa University Hospital · JPYokohama City University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cornelia de Lange syndrome (CdLS) is a rare multisystem disorder with specific dysmorphic features. Pathogenic genetic variants encoding cohesion complex subunits and interacting proteins (e.g., NIPBL, SMC1A, SMC3, HDAC8, and RAD21) are the major causes of CdLS. However, there are many clinically diagnosed cases of CdLS without pathogenic variants in these genes. To identify further genetic causes of CdLS, we performed whole-exome sequencing in 57 CdLS families, systematically evaluating both single nucleotides variants (SNVs) and copy number variations (CNVs). We identified pathogenic genetic changes in 36 out of 57 (63.2 %) families, including 32 SNVs and four CNVs. Two known CdLS genes, NIPBL and SMC1A, were mutated in 23 and two cases, respectively. Among the remaining 32 individuals, four genes (ANKRD11, EP300, KMT2A, and SETD5) each harbored a pathogenic variant in a single individual. These variants are known to be involved in CdLS-like. Furthermore, pathogenic CNVs were detected in NIPBL, MED13L, and EHMT1, along with pathogenic SNVs in ZMYND11, MED13L, and PHIP. These three latter genes were involved in diseases other than CdLS and CdLS-like. Systematic clinical evaluation of all patients using a recently proposed clinical scoring system showed that ZMYND11, MED13L, and PHIP abnormality may cause CdLS or CdLS-like.

Indexed as

Cell Cycle ProteinsChromosomal Proteins, Non-HistoneCo-Repressor ProteinsDe Lange SyndromeDNA-Binding ProteinsDNA Copy Number VariationsE1A-Associated p300 ProteinExome SequencingFamilyFemaleGenetic Association StudiesHistone-Lysine N-MethyltransferaseHumansIntracellular Signaling Peptides and ProteinsMaleMediator ComplexANKRD11 protein, humanCell Cycle ProteinsChromosomal Proteins, Non-HistoneCo-Repressor ProteinsDNA-Binding ProteinsE1A-Associated p300 ProteinEHMT1 protein, humanEP300 protein, humanHistone-Lysine N-MethyltransferaseIntracellular Signaling Peptides and ProteinsKMT2A protein, humanMED13L protein, humanMediator ComplexMethyltransferasesMyeloid-Lymphoid Leukemia ProteinNIPBL protein, humanPHIP protein, humanRepressor ProteinsSETD5 protein, humanStructural Maintenance of Chromosome Protein 1ZMYND11 protein, human

Identifiers

PMID31337854
OpenAlexW2963193978

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.